NASH DAVID
SEC CIK 1251968 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ANIP | ANI PHARMACEUTICALS INC | Dir | 38.6K | — | — | 2 | 2022-04-27 | 2023-05-23 |
Most active insiders at ANIP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lalwani Nikhil | Pres, CEO, Dir | — | $5.05M |
| 2 | Walsh Patrick D | Dir | — | $2.32M |
| 3 | CAREY STEPHEN P. | SVP, CFO | — | $1.78M |
| 4 | Mutz Christopher | HEAD OF RARE DISEASE | — | $1.64M |
| 5 | Gassert Chad | SVP - CORP. DEV, STRATEGY | — | $1.31M |
| 6 | Davis Krista | SVP, Chief HR Off | — | $918.6K |
| 7 | Gutwerg Ori | SVP, GENERICS | — | $621.4K |
| 8 | Cook Meredith | SVP, GC, SEC | — | $453.9K |
| 9 | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | — | $393.8K |
| 10 | HAUGHEY THOMAS | Dir | — | $161.8K |
NASH DAVID made no open-market trades at ANIP in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-24 | 2023-05-23 | ANIP | ANI PHARMACEUTICALS INC | NASH DAVID | Dir | A - Grant | $0.00 | +6,865 | 38.6K | +22% | $0 | |
| 2022-04-29 | 2022-04-27 | ANIP | ANI PHARMACEUTICALS INC | NASH DAVID | Dir | A - Grant | $0.00 | +10.0K | 31.7K | +46% | $0 |
Purchase Sale Sale after option exercise All abbreviations